Pallas Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $847K | Sell |
2,090
-10,535
| -83% | -$4.27M | 0.03% | 366 |
|
|
2025
Q1 | $6.28M | Buy |
12,625
+640
| +5% | +$318K | 0.26% | 80 |
|
|
2024
Q4 | $6.23M | Buy |
11,985
+233
| +2% | +$121K | 0.27% | 79 |
|
|
2024
Q3 | $6.55M | Buy |
11,752
+76
| +0.7% | +$42.4K | 0.28% | 77 |
|
|
2024
Q2 | $6.31M | Buy |
11,676
+418
| +4% | +$226K | 0.28% | 75 |
|
|
2024
Q1 | $6.54M | Buy |
11,258
+1,161
| +11% | +$675K | 0.27% | 73 |
|
|
2023
Q4 | $5.36M | Sell |
10,097
-1,506
| -13% | -$799K | 0.29% | 76 |
|
|
2023
Q3 | $5.04M | Buy |
11,603
+2,555
| +28% | +$1.11M | 0.31% | 70 |
|
|
2023
Q2 | $4.75M | Buy |
9,048
+146
| +2% | +$76.7K | 0.21% | 69 |
|
|
2023
Q1 | $5.11M | Buy |
8,902
+521
| +6% | +$299K | 0.48% | 63 |
|
|
2022
Q4 | $4.98M | Sell |
8,381
-42
| -0.5% | -$24.9K | 0.5% | 57 |
|
|
2022
Q3 | $4.1M | Buy |
8,423
+390
| +5% | +$190K | 0.46% | 67 |
|
|
2022
Q2 | $4.51M | Sell |
8,033
-393
| -5% | -$221K | 0.62% | 48 |
|
|
2022
Q1 | $4.79M | Buy |
8,426
+316
| +4% | +$180K | 0.61% | 49 |
|
|
2021
Q4 | $4.71M | Buy |
8,110
+439
| +6% | +$255K | 0.57% | 44 |
|
|
2021
Q3 | $4.93M | Buy |
7,671
+1,812
| +31% | +$1.16M | 0.54% | 46 |
|
|
2021
Q2 | $3.16M | Buy |
5,859
+921
| +19% | +$496K | 0.44% | 57 |
|
|
2021
Q1 | $2.29M | Buy |
+4,938
| New | +$2.29M | 0.51% | 47 |
|